Therapeutical use of the cannabinoids in psychiatry

By | July 6th, 2016|

The endocannabinoid system and emotional Processing- A pharmacological fMRI study with D9-tetrahydrocannabinol

By | July 6th, 2016|

The Development of Cannabidiol as a Psychiatric Therapeutic- A Review of Its Antipsychotic Efficacy and Possible Underlying Pharmacodynamic Mechanisms

By | July 6th, 2016|

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis- involvement of the endocannabinoid system

By | July 6th, 2016|

Progress in Neuro-Psychopharmacology & Biological Psychiatry

By | July 6th, 2016|

Opposite Effects of D-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

By | July 6th, 2016|

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder_ a preliminary report – ResearchGate

By | July 6th, 2016|

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

By | July 6th, 2016|

Motor effects of delta 9 THC in cerebellar Lurcher mutant mice

By | July 6th, 2016|

Long term marijuana users seeking medical cannabis in California (2001–2007)- demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants

By | July 6th, 2016|